Author Correction: Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells.
作者信息
Huang Rong, Wang Yingbin, Teng Haitao, Xu Mengjun, He Kexin, Shen Yingzhuo, Guo Guo, Feng Xinyu, Li Tianhan, Zhou Binhui, Bajenoff Marc, Lawrence Toby, Liang Yinming, Lu Liaoxun, Zhang Lichen
机构信息
Laboratory of Genetic Regulators in the Immune System, School of Medical Technology, Xinxiang Medical University, Xinxiang, China.
Centre d'immunologie de Marseille-Luminy, Aix-Marseille University, CNRS, INSERM, Marseille, France.
出版信息
BMC Biol. 2025 Jun 15;23(1):165. doi: 10.1186/s12915-025-02285-w.
Abstract
摘要
相似文献
1
Author Correction: Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells.作者更正：黑色素瘤中的酪氨酸酶抑制PD-1缺陷型T细胞的抗肿瘤活性。
BMC Biol. 2025 Jun 15;23(1):165. doi: 10.1186/s12915-025-02285-w.
2
Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells.黑色素瘤中的酪氨酸酶会抑制PD-1缺陷型T细胞的抗肿瘤活性。
BMC Biol. 2025 May 15;23(1):135. doi: 10.1186/s12915-025-02237-4.
3
Retroviral infection with human tyrosinase-related protein-1 (TRP-1) cDNA upregulates tyrosinase activity and melanin synthesis in a TRP-1-deficient melanoma cell line.用人酪氨酸酶相关蛋白1（TRP-1）cDNA进行逆转录病毒感染，可上调TRP-1缺陷型黑色素瘤细胞系中的酪氨酸酶活性和黑色素合成。
J Invest Dermatol. 1996 Apr;106(4):744-52. doi: 10.1111/1523-1747.ep12345799.
4
Dysregulation of tyrosinase activity: a potential link between skin disorders and neurodegeneration.酪氨酸酶活性失调：皮肤疾病与神经退行性疾病之间的潜在联系。
J Pharm Pharmacol. 2024 Jan 6;76(1):13-22. doi: 10.1093/jpp/rgad107.
5
Anti-melanoma vaccines engineered to simultaneously modulate cytokine priming and silence PD-L1 characterized using myeloid-derived suppressor cells as a readout of therapeutic efficacy.以髓系来源的抑制性细胞作为治疗效果的读数，对经过工程改造以同时调节细胞因子启动和沉默PD-L1的抗黑色素瘤疫苗进行表征。
Oncoimmunology. 2014 Jul 3;3(7):e945378. doi: 10.4161/21624011.2014.945378. eCollection 2014.
6
Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytes.PD-L1 靶向α治疗联合 PD-1 缺陷型黑色素瘤特异性人 T 淋巴细胞过继转移治疗的抗肿瘤疗效。
Oncoimmunology. 2021 Jun 27;10(1):1940676. doi: 10.1080/2162402X.2021.1940676. eCollection 2021.
7
8
Maltol has anti-cancer effects via modulating PD-L1 signaling pathway in B16F10 cells.麦芽酚通过调节B16F10细胞中的PD-L1信号通路发挥抗癌作用。
Front Pharmacol. 2023 Sep 5;14:1255586. doi: 10.3389/fphar.2023.1255586. eCollection 2023.
9
PD-L1-Independent Mechanisms Control the Resistance of Melanoma to CD4 T Cell Adoptive Immunotherapy.PD-L1 非依赖性机制控制黑色素瘤对 CD4 T 细胞过继免疫治疗的耐药性。
J Immunol. 2018 May 1;200(9):3304-3311. doi: 10.4049/jimmunol.1701617. Epub 2018 Mar 30.
10
Nitroprusside induces melanoma ferroptosis with serum supplementation and prolongs survival under serum depletion or hypoxia.硝普钠在血清补充的情况下诱导黑素瘤发生铁死亡，并在血清耗竭或缺氧条件下延长生存。
Biochem Biophys Res Commun. 2020 May 7;525(3):626-632. doi: 10.1016/j.bbrc.2020.02.107. Epub 2020 Feb 29.
本文引用的文献
1
Tyrosinase in melanoma inhibits anti-tumor activity of PD-1 deficient T cells.黑色素瘤中的酪氨酸酶会抑制PD-1缺陷型T细胞的抗肿瘤活性。
BMC Biol. 2025 May 15;23(1):135. doi: 10.1186/s12915-025-02237-4.
Zotero 插件